Innovators: NEWS RELEASE - GROUND-BREAKING DISCOVERY IN CANCER TREATMENT

GENERAL PRESS RELEASES

     

    NEWS RELEASE - GROUND-BREAKING DISCOVERY IN CANCER TREATMENT

    added on March 1, 2018 @ 12:48pm by Kassandra Sharron

    Novel molecule discovery being synthesized for breast cancer drug development

    ST. JOHN’S, NL CANADA – Oceans Ltd., an ocean technology company, today announced it has made a ground-breaking discovery in the properties of Newfoundland and Labrador seaweed that will be a ‘game changer’ in breast cancer treatment.

     

    “For several years, we have been investigating the biological activity of seaweed for developing and commercializing natural health and pharmaceutical products,” says Judith Bobbitt, the company’s President and Chief Executive Officer.  “Oceans Ltd. has sampled 60 to 70 seaweed species in Newfoundland and Labrador’s coastal waters, and the results of our research has led to the discovery of anti-cancer properties.”

    Utilizing a crude extract from the seaweed, in-vitro and in-vivo studies have conclusively demonstrated effectiveness in inhibiting the growth of breast cancer cells.  “We have also successfully characterized the molecule structure and have discovered a novel molecule not previously identified,” says Bobbitt.

     

    Most recently, a study was conducted to correlate this compound with anti-cancer activity in mice trials. The study shows that a significant reduction in tumour growth was observed with the pure compound at two different concentrations. This effect represented inhibition of tumour growth since the tumours volume did not progress in size during the trial.

     

    “No obvious abnormalities related to distant tumour metastasis were detected in any of the animals in the study,” adds Bobbitt, “and internal organs, with high potential for metastasis such as the livers, lungs, axillary lymph nodes and diaphragms looked normal.”

     

    It is also important to note that the body weights of mice in all treatment groups remained stable, with no adverse effects observed.

     

    Ocean’s novel molecule, affectionately named GorgonaDosiTM (meaning mermaid potion), is now being synthesized at a prominent research lab, and once complete will be ready for pharmaceutical development. Patents to protect the discovery have been filed.

     

    About Oceans Ltd.

    Oceans Ltd. is an ocean technology company that has been providing environmental services to the oil industry for the past 37 years in marine weather forecasting, iceberg measurement, physical oceanography, and environmental biomonitoring.  During this time the company has been involved in research and development to provide better scientific services, including new methodologies for biomonitoring of species in areas where there are operational oil drilling platforms. Most recently, Oceans Ltd. has been carrying out research in marine algae. The company is comprised of 37 employees, mainly scientists.

     

    Visit Oceans LTD here.